Dequalinium-induced cell death of yeast expressing α-synuclein-GFP fusion protein

Neurochemical Research

Volumn 33, Issue 7, 2008, Pages 1393-1400

  Lee, In Hwan ^a   Kim, Hui Young ^a   Kim, Myunghye ^a   Hahn, Ji Sook ^a   Paik, Seung R ^a  

^a Seoul National University   (South Korea)

Author keywords

Synuclein; Cell death; Dequalinium; Lactacystin; Mitochondria dysfunction; Neurodegenerative disorder; Nuclear malfunction; Parkinson's disease; Yeast

Indexed keywords

ALPHA SYNUCLEIN; CELL PROTEIN; DEQUALINIUM; GREEN FLUORESCENT PROTEIN; LACTACYSTIN;

ARTICLE; CELL DEATH; CELL MEMBRANE PERMEABILITY; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; YEAST CELL;

ACETYLCYSTEINE; ALPHA-SYNUCLEIN; ANTI-INFECTIVE AGENTS, LOCAL; BENZIMIDAZOLES; BLOTTING, WESTERN; DEQUALINIUM; FLUORESCENT DYES; GREEN FLUORESCENT PROTEINS; ORGANIC CHEMICALS; PLASMIDS; PROTEASOME ENDOPEPTIDASE COMPLEX; RECOMBINANT FUSION PROTEINS; SACCHAROMYCES CEREVISIAE; YEASTS;

EID: 44549084064     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-008-9598-8     Document Type: Article

References (30)

1. Spillantini MG, Schmidt ML, Lee VM-Y et al (1997) α-Synuclein in Lewy bodies. Nature 388:839-840
2. Spillantini MG, Crowther RA, Jakes R et al (1998) α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc Natl Acad Sci USA 95:6469-6473
3. Masliah E, Rockenstein E, Veinbergs I et al (2000) Dopaminergic loss and inclusion body formation in α-synuclein mice: Implications for neurodegenerative disorders. Science 287:1265-1269
4. Feany MB, Bender WW (2000) A Drosophila model of Parkinson's disease. Nature 404:394-398
5. Spillantini MG, Goedert M (2000) The α-synucleinopaphies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. Ann NY Acad Sci 920:16-27
6. Weinreb PH, Zhen W, Poon AW et al (1996) NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. Biochemistry 35:13709-13715
7. Conway KA, Harper JD, Lansbury PT Jr (2000) Fibrils formed in vitro from α-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid. Biochemistry 39:2552-2563
8. Hashimoto M, Hsu LJ, Sisk A et al (1998) Human recombinant NACP/α-synuclein in aggregated and fibrillated in vitro: Relevance for Lewy body disease. Brain Res 799:301-306
9. Goldberg MS, Lansbury PT Jr (2000) Is there a cause-and-effect relationship between α-synuclein fibrillization and Parkinson's disease? Nat Cell Biol 2:E115-E119
10. Volles MJ, Lee S-J, Rochet J-C et al (2001) Vesicle permeabilization by protofibrillar α-synuclein: implications for the pathogenesis and treatment of Parkinson's disease. Biochemistry 40:7812-7819
11. Goedert M, Spillantini MG, Davies SW (1998) Filamentous nerve cell inclusions in neurodegenerative diseases. Curr Opin Neurobiol 8:619-632
12. Kodali R, Wetzel R (2007) Polymorphism in the intermediates and products of amyloid assembly. Curr Opin St Biol 17:48-57
13. Shin H-J, Lee E-K, Lee J-H et al (2000) Eosin interaction of α-synuclein leading to protein self-oligomerization. Biochim Biophys Acta 1481:139-146
14. Lee E-N, Cho H-J, Lee C-H et al (2004) Phthalocyanine tetrasulfonates affect the amyloid formation and cytotoxicity of α-synuclein. Biochemistry 43:3704-3715
15. Weiss MJ, Wong JR, Ha CS et al (1987) Dequalinium, a topical antimicrobial agent, displays anticarcinoma activity based on selective mitochondrial accumulation. Proc Natl Acad Sci USA 84:5444-5448
16. 14C]dequalinium cross-links phenylalanine-403 or phenylalanine-406 of an α subunit to a site or sites contained within residues 440-459 of a β subunit. Biochemistry 32:2219-2227
17. Rotenberg SA, Smiley S, Ueffing M et al (1990) Inhibition of rodent protein kinase C by the anticarcinoma agent dequalinium. Cancer Res 50:677-685
18. Bodden WL, Palayoor ST, Hait WN (1986) Selective antimitochondrial agents inhibit calmodulin. Biochem Biophys Res Commun 135:574-582
19. Lee C-H, Kim HJ, Lee J-H et al (2006) Dequalinium-induced protofibril formation of α-synuclein. J Biol Chem 281:3463-3472
20. Outeiro TF, Lindquist S (2003) Yeast cells provide insight into alpha-synuclein biology and pathology. Science 302:1772-1775
21. Davidson WS, Jonas A, Clayton DF et al (1998) Stabilization of α-synuclein secondary structure upon binding to synthetic membranes. J Biol Chem 273:9443-9449
22. Singleton AB, Farrer M, Johnson J et al (2003) α-Synuclein locus triplication causes Parkinson's disease. Science 302:841
23. Sharma N, Brandis KA, Herrera SK et al (2006) alpha-Synuclein budding yeast model: toxicity enhanced by impaired proteasome and oxidative stress. J Mol Neurosci 28:161-178
24. Chen Q, Ding Q, Keller JN (2005) The stationary phase model of aging in yeast for the study of oxidative stress and age-related neurodegeneration. Biogerontology 6:1-13
25. Dixon C, Mathias N, Zweig RM et al (2005) Alpha-synuclein targets the plasma membrane via the secretory pathway and induces toxicity in yeast. Genetics 170:47-59
26. Hashimoto M, Rockenstein E, Crews L et al (2003) Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases. Neuro Mol Med 4:21-35
27. Flower TR, Chesnokova LS, Froelich CA et al (2005) Heat shock prevents alpha-synuclein-induced apoptosis in a yeast model of Parkinson's disease. J Mol Biol 351:1081-1100
28. Chen H, Chomyn A, Chan DC (2005) Disruption of fusion results in mitochondrial heterogeneity and dysfunction. J Biol Chem 280:26185-26192
29. Zhang X, Xie W, Qu S et al (2005) Neuroprotection by iron chelator against proteasome inhibitor-induced nigral degeneration. Biochem Biophys Res Commun 333:544-549
30. Yu S, Li X, Liu G et al (2007) Extensive nuclear localization of α-synuclein in normal rat brain neurons revealed by a novel monoclonal antibody. Neuroscience 145:539-555